Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies
if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the
same subfield and year (this is the minimum needed to enter the top 1%, not the average
within it), or reaches the top citation threshold in at least one of its specific research
topics.
Topotecan versus paclitaxel for the treatment of recurrent epithelial ovarian cancer.
1997532 citationsW ten Bokkel Huinink, Martin Gore et al.Journal of Clinical Oncologyprofile →
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late)
cites ·
hero ref
This map shows the geographic impact of C Scarabelli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C Scarabelli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C Scarabelli more than expected).
This network shows the impact of papers produced by C Scarabelli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C Scarabelli. The network helps show where C Scarabelli may publish in the future.
Co-authorship network of co-authors of C Scarabelli
This figure shows the co-authorship network connecting the top 25 collaborators of C Scarabelli.
A scholar is included among the top collaborators of C Scarabelli based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with C Scarabelli. C Scarabelli is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
Campagnutta, E, et al.. (1999). Treatment of vaginal intraepithelial neoplasia (VAIN) with the carbon dioxide laser.. PubMed. 26(2). 127–30.5 indexed citations
Huinink, W ten Bokkel, Martin Gore, J Carmichael, et al.. (1997). Topotecan versus paclitaxel for the treatment of recurrent epithelial ovarian cancer.. Journal of Clinical Oncology. 15(6). 2183–2193.532 indexed citations breakdown →
Scarabelli, C, Angelo Gallo, E Campagnutta, et al.. (1994). Pelvic recurrences in cervical cancer: multimodal treatment with sequential intra-arterial chemotherapy and surgery. 7(1). 12–16.1 indexed citations
13.
Sopracordevole, Francesco, et al.. (1993). The transretinoic acid in the treatment of cervical intraepithelial neoplasia [1]. 11(1). 33–34.3 indexed citations
14.
Scarabelli, C, et al.. (1993). [Splenectomy in cytoreductive surgery in ovarian cancer].. PubMed. 45(1-2). 19–25.2 indexed citations
Scarabelli, C, et al.. (1988). Hypogastric vein ligation during oncologic surgery as thromboembolic disease prevention.. PubMed. 9(3). 270–2.1 indexed citations
18.
Scarabelli, C, E Campagnutta, & Maria Cristina Manara. (1981). Prognostic value of skin test in patients affected by advanced ovarian cancer and treated with immunochemotherapy.. PubMed. 2(3). 129–33.1 indexed citations
19.
Scarabelli, C, et al.. (1978). [Role of loco-regional chemotherapy in the treatment of tumors of the cervix].. PubMed. 29(7-8). 611–26.2 indexed citations
20.
Scarabelli, C, et al.. (1977). [Value of lymphography in gynecologic neoplasms].. PubMed. 29(12). 963–9.1 indexed citations
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.